Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy-Reference-Cited by-同舟云学术

Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy

Published:2021-01-18 Issue:1 Volume:15 Page:82-92
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Wu Xiaoning^ORCID,Zhou Jialing,Sun Yameng,Ding Huiguo,Chen Guofeng,Xie Wen,Piao Hongxin,Xu Xiaoyuan,Jiang Wei,Ma Hui,Ma Anlin,Chen Yongpeng,Xu Mingyi,Cheng Jilin,Xu Youqing,Meng Tongtong,Wang Bingqiong,Chen Shuyan,Shi Yiwen,Kong Yuanyuan,Ou Xiaojuan,You Hong,Jia Jidong^ORCID

Funder

National Major Science and Technology Projects of China

Beijing Municipal Commission of Science and Technology

the Digestive Medical Coordinated Devloment center of Beijing Hospitals Authority

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-020-10114-1.pdf

Reference31 articles.

1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55.

2. World Health Orgnization. Global hepatitis report-2017. https://www.hoint/hepatitis/publications/global-hepatitis-report2017/en/. 2017. Acessd June 02 2020

3. van Bommel F, Berg T. Treatment of HBV related cirrhosis. Liver Int. 2013;33(Suppl 1):176–81.

4. Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015;62(4):956–67.

5. Tsai MC, Chen CH, Hu TH, Lu SN, Lee CM, Wang JH, Hung CH. Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs. J Formos Med Assoc. 2017;116(7):512–21.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive approach to controlling chronic hepatitis B in China;Clinical and Molecular Hepatology;2024-04-01

2. An Analysis of the Factors Influencing Disease-Free and Overall Survival Time after Curative Resection for Hepatocellular Carcinoma;Advances in Clinical Medicine;2024

3. Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis;Hepatology International;2023-08-19

4. Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients;Clinical and Molecular Hepatology;2023-07-01

5. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions;World Journal of Gastroenterology;2022-11-07